Want to see AU:NGS full AI Analyst Report?
Nutritional Growth Solutions Ltd. (NGS) AI Stock Analysis
Nutritional Growth Solutions Ltd.
(ASX:NGS)
The score is driven mainly by weak financial performance, especially shrinking revenue, persistent losses, and negative cash flow. Flat technicals and loss-based valuation also keep the rating subdued, while the excluded earnings call and corporate events add no influence.
Nutritional Growth Solutions Ltd. (NGS) vs. iShares MSCI Australia ETF (EWA)
- Market Cap
- AUD 3.25M
- Dividend Yield
- ―
- Average Volume (3M)
- 923.68K
- Price to Earnings (P/E)
- -0.0
- Beta (1Y)
- -0.50
- Revenue Growth
- -33.05%
- EPS Growth
- 94.22%
- Country
- Australia
- Employees
- 6
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Nutritional Growth Solutions Ltd. Business Overview & Revenue Model
Company Description
Headquartered in Tel Aviv, Israel, Nutritional Growth Solutions Ltd. is an enterprise focused on developing, producing, and marketing protein supplements specifically tailored for pediatric use. These products reach consumers both domestically and in...
Nutritional Growth Solutions Ltd. Financial Statement Overview
Summary
Severe revenue decline, persistent losses, negative operating cash flow, and volatile equity/debt levels weigh heavily on the score. Minor improvement in recent EBIT and partial balance sheet recovery prevent an even lower result.
Income Statement
12Very NegativeBalance Sheet
25NegativeCash Flow
8Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.48M | 1.68M | 2.48M | 3.06M | 2.95M | 3.04M |
| Gross Profit | 539.22K | 263.89K | 811.00K | 842.00K | 1.44M | 1.36M |
| EBITDA | -645.80K | -1.66M | -2.45M | -3.01M | -4.28M | -4.60M |
| Net Income | -424.16K | -1.77M | -2.54M | -2.89M | -4.25M | -4.78M |
Balance Sheet | ||||||
| Total Assets | 987.57K | 1.79M | 709.00K | 936.00K | 3.03M | 3.44M |
| Cash, Cash Equivalents and Short-Term Investments | 289.87K | 517.35K | 31.00K | 172.00K | 1.52M | 3.00M |
| Total Debt | 0 | 504.34K | 162.00K | 362.00K | 37.00K | 73.00K |
| Total Liabilities | 578.75K | 1.55M | 1.37M | 1.11M | 954.00K | 626.97K |
| Stockholders Equity | 408.82K | 240.16K | -658.00K | -177.00K | 2.08M | 2.81M |
Cash Flow | ||||||
| Free Cash Flow | -678.17K | -1.03M | -1.93M | -2.35M | -6.98M | -3.74M |
| Operating Cash Flow | -665.40K | -1.25M | -1.93M | -2.35M | -6.97M | -3.69M |
| Investing Cash Flow | 0 | 0 | 0 | 0 | -4,000 | -63.06K |
| Financing Cash Flow | 863.91K | 1.77M | 1.78M | 998.00K | 2.21M | 3.42M |
Nutritional Growth Solutions Ltd. Peers Comparison
Overall Rating
AU:BLS84Outperform
AU:NOU49Neutral
AU:BUB48Neutral- AU:NGS44Neutral
AU:AHF41Neutral
AU:NUC37Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| AU:BLS | 84Outperform | AUD 224.26M | 23.09 | 56.29% | ― | 160.87% | 188.14% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| AU:NOU | 49Neutral | AUD 33.25M | -0.51 | 13.40% | ― | 8.82% | 55.22% |
| AU:BUB | 48Neutral | AUD 67.13M | -14.62 | -11.08% | ― | 9.08% | -183.87% |
| AU:NGS | 44Neutral | AUD 19.28M | -0.01 | -130.72% | ― | -33.05% | 94.22% |
| AU:AHF | 41Neutral | AUD 13.88M | -4.21 | -12.90% | ― | 0.46% | 46.48% |
| AU:NUC | 37Underperform | AUD 10.98M | -1.28 | -88.51% | ― | 11.96% | -81.99% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AU:NGS | Nutritional Growth Solutions Ltd. | 0.02 | 0.00 | 0.00% | |
| AU:NOU | Noumi Limited | 0.12 | -0.01 | -7.69% | |
| AU:AHF | Australian Dairy Nutritionals Group | 0.02 | -0.02 | -55.26% | |
| AU:BLS | Bioxyne Limited | 0.94 | 0.53 | 128.05% | |
| AU:BUB | Bubs Australia Ltd. | 0.07 | -0.08 | -50.67% | |
| AU:NUC | Nuchev Pty Ltd | 0.06 | -0.10 | -62.50% |
Nutritional Growth Solutions Ltd. Corporate Events
Nutritional Growth Solutions widens child nutrition platform with Sprout Organic deal
Nutritional Growth Solutions Ltd. has completed the acquisition of Sprout Organic Pty Ltd and its subsidiary Better Brands 3PL, expanding its children’s nutrition portfolio from infant formula to adolescent growth products under a single platfo...
Nutritional Growth Solutions Issues 7.5m Unquoted Employee Options
Nutritional Growth Solutions Ltd., an ASX-listed nutrition company focused on growth-oriented nutritional products, employs unquoted equity instruments in its employee incentive schemes. These securities form part of a broader strategy to link staff...
Nutritional Growth Solutions Files Final Director Interest Notice for Departing Board Member
Nutritional Growth Solutions Ltd has announced that director Guy Khavia has ceased to be a director of the company effective 1 October 2026. The company lodged a Final Director’s Interest Notice with the ASX indicating that Khavia holds no rele...
Nutritional Growth Solutions Seeks ASX Quotation for 15.8 Million New Shares
Nutritional Growth Solutions Ltd., an ASX-listed nutrition-focused company, has applied for quotation of additional ordinary fully paid shares under the code NGS. The application relates to the issuance of 15,839,238 new securities, expanding the com...
Nutritional Growth Solutions Plans Major Performance Rights Issue
Nutritional Growth Solutions Ltd. has notified the ASX of a proposed issue of new performance rights securities as part of a placement or similar equity arrangement. The filing outlines multiple new classes of performance rights totaling tens of mill...
Nutritional Growth Solutions Plans New Share and Option Issue on ASX
Nutritional Growth Solutions Ltd. has notified the ASX of a proposed placement and related securities issue scheduled for October 1, 2026. The company plans to issue 15,839,238 fully paid ordinary shares along with 7,500,000 options across three new...
Nutritional Growth Solutions Completes Acquisition of Sprout Organic
Nutritional Growth Solutions Ltd. has completed the acquisition of Sprout Organic Pty Ltd, the business behind what is promoted as the world’s first certified organic, 100% plant-based infant formula that meets Food Standards Australia New Zeal...
Nutritional Growth Solutions Discloses Increase in Director’s Indirect Equity Holdings
Nutritional Growth Solutions Ltd, an ASX-listed player in the nutrition and health space, reinforces its growth-focused capital structure by utilizing ordinary shares and incentive options in executive and related-party arrangements. The company̵...
Nutritional Growth Solutions Issues 154 Million New Shares to Advisors, Investors and Directors
Nutritional Growth Solutions has issued 154,220,000 new fully paid ordinary shares over 3 and 4 September 2026, expanding its capital base through a mix of advisory compensation, investor placement, and director fee arrangements. The issuance include...
Nutritional Growth Solutions Seeks ASX Quotation for New Equity Incentive Shares
Nutritional Growth Solutions Ltd., an ASX-listed nutrition-focused company, issues ordinary fully paid shares as part of its equity-based remuneration practices. The business appears to prioritize growth and employee alignment through share-based inc...
Nutritional Growth Solutions Issues 45 Million Unquoted Options Expiring in 2029
Nutritional Growth Solutions Ltd. has notified the market of the issue of 45 million unquoted options, split between 30 million options exercisable at $0.025 and 15 million at $0.04, all expiring on September 4, 2029. The options, issued under previo...
Nutritional Growth Solutions Seeks ASX Quotation for 4.48m New Shares
Nutritional Growth Solutions Ltd. has applied for quotation of 4,480,000 new ordinary fully paid shares on the ASX, with an issue date of 4 September 2026. The application, lodged as an Appendix 2A new announcement, expands the company’s listed...
Nutritional Growth Solutions Issues 20 Million Unquoted Options
Nutritional Growth Solutions Ltd., an ASX-listed nutrition company, develops and markets growth-focused dietary products within the broader health and wellness sector. Its activities center on delivering nutritional solutions aimed at supporting phys...
Nutritional Growth Solutions Seeks ASX Quotation for 20 Million New Shares
Nutritional Growth Solutions Ltd. has applied for quotation of 20,000,000 ordinary fully paid shares on the ASX, with an issue date of 4 September 2026. The new securities, lodged via an Appendix 2A application, expand the company’s quoted shar...
Nutritional Growth Solutions Seeks ASX Quotation for 120 Million Shares
Nutritional Growth Solutions Ltd., listed on the ASX under the code NGS, is a nutrition-focused company whose ordinary fully paid shares are traded on the Australian Securities Exchange, providing investors exposure to its growth strategy in the nutr...
Nutritional Growth Solutions Returns to Profit and Strikes Transformational Sprout Organic Deal
Nutritional Growth Solutions reported half-year revenue of US$706,000 for the period to 30 June 2026, down 18.57% year on year, but swung to a net profit of US$120,000 from a US$1.178 million loss as cost discipline and working capital optimisation t...
Nutritional Growth Solutions Shareholders Back Board and Sprout Acquisition Plans
Shareholders of Nutritional Growth Solutions approved all resolutions at the company’s Annual General Meeting, including the election of directors Manik Pujara, Andrew Grover and Selasi Berdie by strong majorities. The voting results reinforce...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 10, 2026